BTHE Financials 07/16/2014 19:58:13 Boston Therap

BTHE Financials 07/16/2014 19:58:13
Boston Therapeutics Inc
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 323 42 4 -
Cost of Revenue 278 57 6 -
Gross Profit 45 (15) (2) -
Operating Expenses
Research and Development 542 179 194 11
Sales, General and Admin. 4,083 1,269 615 230
Non-Recurring Items - - - -
Other - - - -
Operating Income (4,580) (1,463) (812) (241)
Income From Continuing Operations
Add'l Income/Expense Items (2) (3) - -
Earnings Before Interest and Tax (4,582) (1,466) (812) (241)
Interest Expense 20 18 16 7
Earnings Before Tax (4,602) (1,484) (827) (248)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,602) (1,484) (827) (248)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,602) (1,484) (827) (248)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (4,602) (1,484) (827) (248)